CPIA
BIIB icon

Cornell Pochily Investment Advisors’s Biogen BIIB Stock Holding History

Cornell Pochily Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,336
Closed -$259K – 170
2024
Q3 		$259K Sell
1,336
-30
-2% -$6.28K 0.09% 157
2024
Q2 		$317K Sell
1,366
-75
-5% -$16.3K 0.12% 133
2024
Q1 		$311K Sell
1,441
-105
-7% -$24.6K 0.12% 136
2023
Q4 		$400K Hold
1,546
– – 0.17% 124
2023
Q3 		$397K Hold
1,546
– – 0.17% 123
2023
Q2 		$440K Hold
1,546
– – 0.18% 120
2023
Q1 		$430K Buy
1,546
+10
+0.7% +$2.77K 0.18% 123
2022
Q4 		$425K Buy
1,536
+85
+6% +$24K 0.19% 123
2022
Q3 		$387K Sell
1,451
-108
-7% -$22.9K 0.17% 123
2022
Q2 		$318K Buy
1,559
+10
+0.6% +$2.04K 0.14% 135
2022
Q1 		$326K Buy
1,549
+15
+1% +$3.26K 0.13% 135
2021
Q4 		$368K Sell
1,534
-170
-10% -$43.7K 0.14% 130
2021
Q3 		$482K Hold
1,704
– – 0.21% 108
2021
Q2 		$590K Buy
1,704
+115
+7% +$34.8K 0.26% 98
2021
Q1 		$445K Buy
1,589
+65
+4% +$17.5K 0.21% 101
2020
Q4 		$373K Sell
1,524
-151
-9% -$39K 0.18% 109
2020
Q3 		$475K Sell
1,675
-25
-1% -$6.97K 0.27% 85
2020
Q2 		$455K Buy
1,700
+45
+3% +$13.5K 0.28% 87
2020
Q1 		$524K Buy
1,655
+30
+2% +$9.1K 0.39% 70
2019
Q4 		$482K Sell
1,625
-57
-3% -$15.8K 0.29% 91
2019
Q3 		$392K Sell
1,682
-440
-21% -$102K 0.25% 95
2019
Q2 		$496 Buy
2,122
+21
+1% +$4.85K 0.12% 92
2019
Q1 		$496K Sell
2,101
-210
-9% -$66.1K 0.34% 80
2018
Q4 		$695K Buy
2,311
+187
+9% +$59.7K 0.45% 64
2018
Q3 		$750K Buy
2,124
+38
+2% +$13.1K 0.51% 58
2018
Q2 		$605K Sell
2,086
-46
-2% -$12.9K 0.42% 69
2018
Q1 		$583K Buy
2,132
+146
+7% +$45.3K 0.41% 71
2017
Q4 		$632K Buy
+1,986
New +$637K 0.41% 75

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cornell Pochily Investment Advisors's BIIB Position: Q4 2024 in Review

Cornell Pochily Investment Advisors sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,336 shares — an estimated $259K sold.

Cornell Pochily Investment Advisors first reported a position in BIIB in Q4 2017 and held it in 28 quarters. The position peaked at $750K in Q3 2018. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Cornell Pochily Investment Advisors reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Cornell Pochily Investment Advisors sold 1,336 Biogen shares in Q4 2024, an estimated $259K.
  • Cornell Pochily Investment Advisors first reported a position in Biogen in Q4 2017 and held it in 28 quarters.
  • Cornell Pochily Investment Advisors's Biogen position peaked at $750K in Q3 2018.
  • 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Cornell Pochily Investment Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.